ConductScience.org, home

Paper33404652

Changes in the pharmacological management of rheumatoid arthritis over two decades.

Crossfield SSR and 5 others. Rheumatology (Oxford), 2021. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Changes in the pharmacological management of rheumatoid arthritis over two decades. Papers, record 33404652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33404652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Changes in the pharmacological management of rheumatoid arthritis over two decades.
PubMed
Journal
Rheumatology (Oxford)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2021-10-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crossfield SSRSamantha S Rhttps://orcid.org/0000-0001-7337-3527
2Buch MHMaya Hhttps://orcid.org/0000-0002-8962-5642
3Baxter PPaulhttps://orcid.org/0000-0003-2699-3103
4Kingsbury SRSarah Rhttps://orcid.org/0000-0002-9917-1269
5Pujades-Rodriguez MMarhttps://orcid.org/0000-0002-1375-1028
6Conaghan PGPhilip Ghttps://orcid.org/0000-0002-3478-5665

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal Cortex HormonesMajor topic
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Antirheumatic AgentsMajor topic
Arthritis, RheumatoidMajor topic
Practice Patterns, Physicians'Major topic
Adolescent
Adult
Aged
Aged, 80 and over
Disease Management
Drug Prescriptions
Electronic Health Records
Female
Humans
Male
Middle Aged
Young Adult

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/L01629XMedical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42421966Integrating genetic, epigenetic, and clinical signatures via machine learning for robust prediction of leflunomide response in rheumatoid arthritis: a multi-center validation study.Front Immunol2026https://conductscience.org/library/papers/42421966PubMed
41947112Symptomatic knee osteoarthritis in older Thai adults: prevalence, risk factors, and associations with osteoporosis, sarcopenia, and fall risk-a nationwide cross-sectional study.BMC Public Health2026https://conductscience.org/library/papers/41947112PubMed
41844309Prednisone prescribing for rheumatoid arthritis management in primary care: Mixed-methods study of trends and patient perspectives.Can Fam Physician2026https://conductscience.org/library/papers/41844309PubMed
41488190Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDs.Rheumatol Adv Pract2026https://conductscience.org/library/papers/41488190PubMed
40558221Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025?Clin Pract2025https://conductscience.org/library/papers/40558221PubMed
40471746Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study.Rheumatology (Oxford)2025https://conductscience.org/library/papers/40471746PubMed
39881356Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review.BMC Med2025https://conductscience.org/library/papers/39881356PubMed
39716799A Comprehensive Review on Plant Bioactive Compounds-based Novel Drug Delivery System for the Treatment of Rheumatoid Arthritis.Pharm Nanotechnol2026https://conductscience.org/library/papers/39716799PubMed
39196476Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK.Pharmacoecon Open2024https://conductscience.org/library/papers/39196476PubMed
37914177Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System.RMD Open2023https://conductscience.org/library/papers/37914177PubMed
37822018Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink.Rheumatology (Oxford)2024https://conductscience.org/library/papers/37822018PubMed
37324499The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification.Front Pharmacol2023https://conductscience.org/library/papers/37324499PubMed
37172495Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018.Semin Arthritis Rheum2023https://conductscience.org/library/papers/37172495PubMed
36559313Recent Advancements in Drug Delivery of Sinomenine, A Disease-Modifying Anti-Rheumatic Drug.Pharmaceutics2022https://conductscience.org/library/papers/36559313PubMed
36263118Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study.Front Pharmacol2022https://conductscience.org/library/papers/36263118PubMed
35896282'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps.RMD Open2022https://conductscience.org/library/papers/35896282PubMed
35885030Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis.Biomedicines2022https://conductscience.org/library/papers/35885030PubMed
34802085Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.Int Ophthalmol2022https://conductscience.org/library/papers/34802085PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33404652

GET https://conductscience.org/api/papers/v1/33404652/authors